June 26-27, 2008 SCYNEXIS will participate in the Drugs for Neglected Diseases initiative Stakeholders’ Meeting in New York City and will co-host a public briefing, “Uniting the Global Research Community against Neglected Diseases” with DNDi in Research Triangle Park, North Carolina.
June 17-20, 2008 SCYNEXIS will participate in the BIO 2008 Conference in San Diego.
June 9, 2008 SCYNEXIS is sponsoring a public seminar, “Current Perspectives on the Role of Cyclophilin Inhibitors in the Pathophysiology and Treatment of Human Disease,” from 9:00 AM to 12:00 Noon at the Hilton Hotel - Raleigh-Durham Airport At Research Triangle Park.
May 13-14, 2008 SCYNEXIS will participate in the Allicense 2008 Conference in San Francisco.
April 28-30, 2008 SCYNEXIS will attend the 2008 Bio-IT Conference in Boston.
April 12-18, 2008 SCYNEXIS will exhibit as a sponsoring company at the BioVision 2008 Conference in Alexandria, Egypt.
March 10-12, 2008 SCYNEXIS will present at the BIO Ventures For Global Health Forum 2008 in Reston, Va.
January 29 to February 1, 2008 SCYNEXIS will participate as an exhibitor at the INFORMEX USA Conference In New Orleans.
January 7-10, 2008 SCYNEXIS will attend the JP Morgan Annual Healthcare Conference to be held in San Francisco.
December 5, 2007 SCYNEXIS will present at the BMO Capital Markets 2007 Focus on Healthcare Conference to be held in New York.
November 2-6, 2007 SCYNEXIS will attend the 58th Annual Meeting of the American Association for the Study of Liver Diseases to be held in Boston.
November 4-8, 2007 SCYNEXIS will attend the 56th Annual Meeting of the American Society of Tropical Medicine and Hygiene in Philadelphia.
November 6, 2007 SCYNEXIS will present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference to be held in New York.
September 17-21, 2007 SCYNEXIS will attend the 47th ICAAC (Interscience Conference on Antimicrobial Agents & Chemotherapy) in Chicago.
August 19-23, 2007 SCYNEXIS will attend the American Chemical Society (ACS), 234th National Meeting & Exposition in Boston.
August 6-9, 2007 SCYNEXIS will exhibit at IBC’s 12th Annual World Congress of Drug Discovery & Development of Innovative Therapeutics in Boston.
July 14-18, 2007 SCYNEXIS will attend the American Association of Veterinary Parasitology in Washington, D.C.
July 9-13, 2007 SCYNEXIS will participate in the 8th Annual LOL Bioanalytical Conference in Merrimac, Wisconsin as an event sponsor.
June 26-28, 2007 SCYNEXIS will participate as a sponsor and a presenting company at the 14th Annual Euro-Biotech Forum in Paris, France.
June 3-7, 2007 SCYNEXIS will participate as a sponsor and an exhibitor at the 40th National Organic Chemistry Symposium being held in Durham, North Carolina.
May 24, 2007 SCYNEXIS will give a presentation at the 9th Annual C21 BioVentures Conference in Monterey, CA.
May 15, 2007 Merial Limited and SCYNEXIS, Inc. announce the expansion of their research collaboration.
May 6-9, 2007 SCYNEXIS will give a Business Forum Presentation at the BIO International Convention in Boston, MA
March 26-28, 2007 SCYNEXIS to Exhibit at the Society of Toxicology (SOT), 2007 ToxExpo in Charlotte, NC
March 12, 2007 SCYNEXIS to present at the Cowen and Company 27th Annual Health Care Conference at 3:30 P.M. EDT in Boston, MA.
February 13-16, 2007 SCYNEXIS to Exhibit at Informex 2007 USA in San Francisco, CA
January 9, 2007 SCYNEXIS, Inc. Receives Preclinical Milestone Payment In Collaboration with Merck
December 6, 2006 SCYNEXIS announces research agreement with Merck for discovery of novel oncology agents
October 29 - November 1, 2006 SCYNEXIS to Exhibit at 2006 AAPS Annual Meeting and Exposition in San Antonio, TX
October 27-31, 2006 SCYNEXIS to Provide a Poster Presentation at the American Association for the Study of Liver Diseases Meeting in Boston.
September 27-30, 2006 SCYNEXIS to Provide a Poster Presentation at the American Society for Microbiology 46th Annual International Conference on Antimicrobial Agents and Chemotherapy (ICAACTM) in San Francisco
September 10-14, 2006 SCYNEXIS to Provide Oral Presentation at the 232nd American Chemical Society National Meeting in San Francisco
August 7-10, 2006 SCYNEXIS to Exhibit at the IBC Drug Discovery & Technology Conference in Boston
June 27-29, 2006 SCYNEXIS to Present at Euro-Biotech Forum in Paris, France
May 18, 2006 SCYNEXIS to Present at 23rd Triangle Chromatography Symposium and Instrument Exhibit in Raleigh, NC
May 2-3, 2006 SCYNEXIS to Present at Venture06 in Pinehurst, NC
April 11, 2006 SCYNEXIS to Present at BIO in Chicago, IL
March 28, 2006 SCYNEXIS announces new board chairman and new board member appointments of well-known pharmaceutical executives
March 26-30, 2006 SCYNEXIS to present two posters at the American Chemical Society in Atlanta, GA
February 14-17, 2006 SCYNEXIS to exhibit and present at Informex 2006 in Orlando, FL
January 5, 2006 SCYNEXIS Europe is now Selcia following spin off from SCYNEXIS, Inc
December 1, 2005 SCYNEXIS to present at SEBIO (Southeast BIO) Conference in Charleston, SC
November 6-10, 2005 SCYNEXIS to exhibit at 2005 (AAPS) American Association of Pharmaceutical Scientists Annual Meeting and Exposition in Nashville, TN.
October 26-27, 2005 SCYNEXIS to present and exhibit at 2005 Mid-Atlantic Bio conference in Washington D.C.
October 11, 2005 Teijin Pharma and SCYNEXIS Sign Research Agreement.
September 30, 2005 SCYNEXIS, Inc. Selected As a Primary Research Partner for Merial.